Stock News

Breaking News: Palliser Capital Reacts to Rio Tinto’s Game-Changing Move for Australian Shareholders at Limited AGM Description: LONDON–(BUSINESS WIRE)–Palliser Capital (“Palliser”) today reacts to the decision by Rio Tinto’s Board to allow the shareholders of Rio Tinto Limited (ASX: RIO) to vote on its co-filed resolution at the upcoming Limited

Breaking News: Birchtech’s Fiscal 2025 Revenue Projections Unveiled! Management Expects Revenues of at Least $23 Million in 2025 Excluding Potential Cash Received from IP Defense as well as Water Treatment Revenues Air Business Run Rate Expected to Surpass $40 Million in 2026 CORSICANA, Texas, March 04, 2025 (GLOBE NEWSWIRE) —

Compugen Crushes Expectations: A Look at Their Record-Breaking 2024 Results Description: Clinical data presented at SITC 2024 supports further development of COM701, potential first-in-class anti-PVRIG antibody. On track to initiate a randomized adaptive platform trial of COM701 maintenance therapy in patients with platinum-sensitive ovarian cancer, scheduled to start in Q2

Breaking News: Pomerantz Law Firm Takes Action Against Walgreens Boots Alliance Inc. for Shareholder Misconduct Description: NEW YORK, March 3, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain officers. The class

Revving Up for Success: ZOOZ Power Takes the Lead as China’s Premier Charge Point Operator with Revolutionary Boosting System Description: Tel-Aviv, Israel, March 03, 2025 (GLOBE NEWSWIRE) — ZOOZ Power Ltd. (Nasdaq: ZOOZ, TASE: ZOOZ), a leading provider of flywheel-based power boosters and energy management systems for enabling ultra-fast EV charging

Join Cardiol Therapeutics at the Prestigious TD Cowen 45th Annual Health Care Conference! Toronto, Ontario–(Newsfile Corp. – March 3, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease

Taking Flight: Volatus Aerospace and Draganfly Join Forces Serving Elite Geospatial Power Utility Clients Toronto, ON, and Saskatoon, SK – March 03, 2025 Volatus Aerospace Inc. (TSXV: FLT) (OTCQX: TAKOF) (Frankfurt: ABB) (“Volatus”) and Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly”) announced today a strategic collaboration to address

Breaking News: Monolithic Power Faces Securities Fraud Lawsuit! Overview LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Monolithic Power Systems, Inc. (“Monolithic Power” or “the Company”) (NASDAQ:MPWR) for violations

Uncovering the Truth: Levi and Kors Investigate Teleflex Incorporated for Business and Professional Services NEW YORK, NY / ACCESS Newswire / March 1, 2025 Levi & Korsinsky notifies investors that it has commenced an investigation of Teleflex Incorporated (“Teleflex Incorporated”) (NYSE:TFX) concerning possible violations of federal securities laws. On February

Join the Fight for Justice: The Schall Law Firm Calls on Shareholders with Losses to Take Action LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or

Breaking News: Pomerantz Law Firm Launches Class Action Lawsuit for Investors March 1, 2025 New York, NY / ACCESS Newswire Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ:WBA) and certain officers. The class action, filed in the

Attention Investors: Pomerantz Law Firm Files Class Action Lawsuit – What You Need to Know New York City, NY / ACCESS Newswire / March 1, 2025 Pomerantz LLP announces that a class action lawsuit has been filed against Micron Technology, Inc. (“Micron” or the “Company”) (NASDAQ:MU) and certain officers. The

Unlocking Success: Rosen, a Top Law Firm, Urges Investment in Neumora Therapeutics Inc. New York, NY / ACCESS Newswire / March 1, 2025 / Rosen Law Firm PA Why Should You Invest in Neumora Therapeutics Inc.? Rosen Law Firm, a global investor rights law firm, has been at the forefront

Unpacking Holcim AG’s Q4 2024 Earnings Call: Insights and Highlights Description: Holcim AG (OTCPK:HCMLF) recently held their Q4 2024 Results Conference Call on February 28, 2025, at 5:00 AM ET. The call featured key company executives including Bernd Pomrehn – IR Head, Miljan Gutovic – CEO, and Steffen Kindler –

Longeveron’s Exciting Journey: A Look at 2024 Financial Results and Future Plans! Pivotal Phase 2b Clinical Trial Progress The Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left Heart Syndrome (HLHS), a rare pediatric disease and orphan-designated indication, has achieved more than 90% enrollment and is